More than 3M Americans live with emphysema, yet less than 1% receive interventional treatment for the debilitating lung condition. Apreo Health is working to change that. Its minimally invasive solution is a safer way to help more people breathe easier and live better. We’re

Five years running on @Inc’s 2025 Founder-Friendly Investors list. 🎉 Our invited guest approach to partnership means that we support founders through trust, integrity, and empowerment – helping them fulfill their vision while scaling sustainably. Grateful to our portfolio

Conversational AI is transforming how healthcare systems communicate and deliver care. The main takeaway? Automation alone isn’t enough. Without patient data and cross-channel logic, AI agents reach their limit. We mapped the landscape and backed @Hyro_AI for leading the next

We’re proud to back @hyro_ai, an enterprise-grade AI agents platform improving access to healthcare and enhancing patient experience. Read more on how Hyro helps health systems communicate smarter and faster.

Excited to partner with @psdcitywide as it helps municipalities modernize infrastructure management across North America. A standout example of a founder-led team scaling purpose-built technology for the public sector. Learn more:

The new question for marketing leaders: Not “How do we rank?” But “How do we stay remembered?” Read Renée’s full perspective on the shift from SEO to GEO:

Generative AI is reshaping how buyers discover and decide. The multi-step journey around search often happens in a single prompt-response now. Here’s what that means for CMOs and marketing leaders ⬇️

For CMOs, the SEO playbook is being upended. As SEO strategist Andrew Lennon notes, the buyer’s journey is collapsing — and Renée Cohen, Norwest Principal and Marketing Operating Executive, explains why it’s time to think in terms of GEO: 🔹Compete for model memory 🔹Earn

Massive congrats to @youdotcom on its $100M Series C at a $1.5B valuation! The agentic era needs infrastructure that’s secure, scalable, and transformative... exactly what @RichardSocher and team are building. Proud to back them! https://t.co/cM4O2x8N8B

Today, @raincards announced its $58M Series B, led by @SapphireVC. This raise reflects not only their superb execution but also the accelerating enterprise adoption of stablecoins globally. We’ve been fortunate to back Rain since day one and to lead their Series A just five

I want to share an update that I won’t be competing this summer. Instead I’ll be able to spend more quality time with Bridget and Eevi and dive into career interests beyond swimming. I’ve joined the Growth Equity team @NorwestVP focusing on sports investment opportunities. And

We’re pleased to share that we’ve dosed the first patient in our Phase 2 CIDP trial evaluating NVG-2089, a recombinant Fc fusion protein designed to replicate key immunomodulatory functions of IVIg with improved consistency and convenience. https://t.co/uorfS5dcZZ

We’re proud to invest in @ClassiqTech’s $110 million in Series C — the largest round ever for a quantum software company. In the words of CEO and co-founder Nir Minerbi, Classiq is building “the Microsoft of quantum computing” – the software stack that powers real-world quantum

Revenue recognition is one of the most painful, high-stakes challenges in the back office. It’s only getting harder as AI unlocks new, usage-based business models. Thrilled to support the team at @RightRevInc as they announce their $13M Series A.

Enterprises are overwhelmed by complex, unmanaged access permissions. @vezainc is tackling this with an identity-first security approach, and we’re proud to support its $108M Series D. More from @zilberman & @thakurtarun about why identity is the front line of cybersecurity:

Our next guest (Ep.17) on BioVenture VoiCes will be Tiba Aynechi, General Partner at @NorwestVP. She describes her journey from a PhD in Biophysics and early work in computational drug discovery and her ~20 yr career in life sciences venture investing, including 12 years at

Listen to Episode 17 of @BioVentureVoiCe video podcast w/ Tiba Aynechi of @NorwestVP and hear about how she is applying her biophysics/computational drug discovery training and her ~20 years of deal making/VC investing, including 12 yrs at @novoholdings / Novo Ventures, to